In 2023 and 2024, we are expecting significant M&A in life sciences. As I captured in my…
In 2015 I was frustrated by the arrogance of science in my industry, life sciences, and the lack of appreciation…
I’ve seen a lot change in biotech, medical device, diagnostic, and digital health companies over the last 20+ years especially over the last 15 years as a consultant.
This is not a drill. This is really happening.
As part of the system selection process, life sciences companies should be performing…